News & media
NEWS

Türkiye: Virbac acquires its companion animal products distributor

2024/12/03 - Financial public releases

Vignette_corpo_Byzance.jpgOn December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products.

Read more

Let's do it smart: for a more rational use of parasiticides in animal farming

2024/11/29 - Animal health

Vignette_corpo_lets_do_it_smart_FA.jpgOur program, already available to pet veterinarians since 2023,  will also be available to farm animal veterinarians worldwide during 2025. With Let's do it smart, we offer them concrete tools for choosing pest control solutions tailored to the real needs of each farm. This helps preserve the fragile balance between man, animal and ecosystem.

Read more

Well-being at work: fourteen Virbac subsidiaries certified Great Place To Work 2024

2024/11/13 - Career

Handicap Vignette 300x200.jpgFrom January 29 to February 9, we conducted the 2024 Great Place To Work survey among our employees.

As a result of the survey, fourteen of our subsidiaries worldwide have been certified Great Places To Work. This recognition reflects our ongoing commitment to building a corporate culture based on trust and the well-being of our employees.

Read more

2024 third quarter consolidated sales

2024/10/17 - Financial public releases

Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

Read more

The future of cat mobility starts now!

2024/09/30 - Animal health

Vignette_corpo_movoflex_cat.jpg90% of cats over the age of 10  have joint issues1 which can lead to mobility impairment and impact their quality of life. To keep their joints healthy and improve their mobility, our teams have developed a new Movoflex formula dedicated to cats. A novel soft chew, gradually available in Europe from September 2024.

Read more

USA: new partnership with the association for the prevention of pet obesity

2024/09/17 - Animal health

vignette_web_corpo_CP_APOP.jpgThis September, our American teams formed a strategic alliance with the association for pet obesity prevention (APOP) to confront the growing threat of pet obesity in the United States and raise awareness of the importance of pet nutrition.

Read more

Capital reduction

2024/09/13 - Financial public releases

The board of directors announces a capital reduction through cancellation of treasury shares

Read more

2024 half-year results

2024/09/13 - Financial public releases

●    Exceptional business momentum in the first half, with revenue up 16.1% at constant exchange rates

●    Strong growth in adjusted current operating income1 
      ○ +3.4 points compared with 2023 to reach a record level at 21.4% of revenue

●    2024 targets confirmed  
      ○    Revenue growth expected between 7% and 9% at constant exchange rates and scope
      ○    Adjusted current operating income1 expected to be around 16% compared with 15.1% in 2023

Read more

Mastitis: a new tool to improve milk quality

2024/08/12 - Animal health

Corpo_NMC.jpgFor several decades, we have been providing industry professionals with solutions to improve milk production. From August 12-14, our teams will be at the National Mastitis Council to present our Smart DCT tool. Its purpose? To make it easier to implement selective dry-off in herds and improve milk quality worldwide.

Read more

Over 40 years of commitment to dermatology… and we’re only just getting started!

2024/07/26 - Animal health

Vignette_corpo_WCVD.jpgThe quality of dogs' and cats' skin and coat is essential for their health and their bond to humans. That’s probably why, since the 80’s, veterinary dermatology has grown to be the primary reason for consultations in pets. At Virbac, we have been part of this history from the outset, working alongside the founding fathers of modern veterinary dermatology, paving the way for innovation for the well-being of our companion animals. This July, as for every edition since the first one, we are principal sponsor of the 10th World Congress of Veterinary Dermatology. 

Read more

2024 second quarter consolidated sales

2024/07/16 - Financial public releases

Exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions

Read more

Virbac announces executive management changes

2024/07/08 - Company

Virbac-siège.jpgSébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officer

Read more

Guidance update for 2024

2024/07/08 - Financial public releases

Exceptional first-half growth and guidance raised for 2024

Read more

Virbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialist

2024/07/02 - Financial public releases

Virbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialistOn June 21, we finalized the acquisition of Globion's minority shares, bringing our stake to 100%. As planned, this transaction follows the acquisition of a 74% majority stake concluded on November 1, 2023.

Read more

Our food evolves to better support the oral health of small dogs

2024/06/19 - Animal health

Vignette_corpo_HPM_S&T.jpgSmall dogs suffer up to five times more oral disease1 than other dogs. To nourish them while taking care of their oral health, our teams have reformulated our Veterinary HPM Small & Toy food. Launched in Europe in June, the new formula now includes a natural ingredient with proven efficacy against plaque, tartar, bleeding gums and bad breath.

Read more

Europe: experts meet to talk about canine mobility

2024/06/17 - Animal health

Vignette_corpo_symposium_movoflex.jpgIn June, 10 European veterinary experts in canine mobility met in Nice to share with our teams their experience and knowledge on canine mobility disorders.

Read more

Companion animals: first reproductive control guidelines presented!

2024/05/30 - Animal health

Vignette_corpo_webinar.jpgOn April 17, our teams, in collaboration with recognized experts, organized a webinar dedicated to the first WSAVA guidelines on reproductive control for dogs and cats. More than 6,000 veterinarians from around the world expressed interest in this important animal health topic.

Read more

Latin America: supporting good canine vaccination practices

2024/05/28 - Animal health

vignette_corpo_webinar_immuno.jpgMore than 3,500 veterinarians in South America registered for the webinar our teams organized last April. Our goal: to share the latest recommendations on canine vaccination from the World Small Animal Veterinary Association (WSAVA). 

Read more

Europe: our commitment to fight canine leishmaniosis continues

2024/04/19 - Animal health

Vignette_corpo_Leish.jpgFor more than 20 years, our teams have worked to combat this zoonotic disease that threatens the health of dogs and humans alike. In 2024, we continue to work to bring diagnostic, prevention and treatment solutions to veterinarians and dog owners in endemic areas. Our latest stop is France, which will host the Animal Leishmaniosis International Veterinary Event in Nice in April.

Read more

2024 first quarter consolidated sales

2024/04/16 - Financial public releases

Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates

Read more

Virbac acquired Sasaeah, a leading animal health player in Japan.

2024/04/02 - Financial public releases

Sasaeah.jpgOn April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.

Read more

Asia: our teams support growth in canine dermatology

2024/03/28 - Animal health

DAILYDERMA IN ASIA.jpgAs in other parts of the world, around 10%1 of dogs in Asia suffer from atopic dermatitis. Since 2022, our teams have been stepping up their efforts to develop our global DailyDerma program in the region. The goal? To better help Asian veterinarians optimize their dermatology practices and improve the management of skin diseases, especially complex atopic dermatitis. 

Read more

2023 Annual results

2024/03/19 - Financial public releases

●    Revenue up 4.9%, enabling market share gains despite difficulties in 2023

●    2023 operating profitability1 at an all-time high of 23.2% of revenue
     ○ Up 0.4 points compared to 2022 

●    Strong momentum expected in 2024
     ○  Expected revenue growth of 4% to 6% at constant exchange rates and scope
     ○  Operating profitability1 expected to rise by 0,5 point

 

Read more

Europe: new prevention solutions for swine farming

2024/03/07 - Animal health

Swine_vaccination.jpgOne year after the launch of Suigen Rota Coli, our teams in France and Germany are now offering a second vaccine for swine, Suigen APP 2,9,11. This new vaccine complements our solutions for the prevention of major swine diseases, helping farmers to better control the health of their farms.

Read more

Virbac to take a leading position in Japan through the acquisition of Sasaeah

2024/03/06 - Financial public releases

Sasaeah.jpgVirbac announces that it has signed a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of approximately €280 million.

Read more

Virbac: Olivier Charmeil co-opted by the board of directors

2024/01/24 - Career

Olivier_Charmeil_150x200.jpgVirbac announces the appointment of Olivier Charmeil as a new member of the board of directors with effect from December 21, 2023. He replaces Olivier Bohuon, permanent representative of OJB Conseil, within the board of directors and the appointments and compensation committee. 

Read more

Virbac shampoos for dogs and cats get a makeover!

2024/01/23 - Animal health

shampoos.jpgOur range of dermatological (AKI) and hygiene (Allerderm) shampoos has been redesigned to limit ecological impact and simplify use for pet owners. The new packaging is now made from recycled plastic, while the innovative formulations, which have been constantly improved over the last few decades, remain unchanged.

Read more

2023 fourth quarter consolidated sales

2024/01/17 - Financial public releases

Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5%

Read more

Happy New Year 2024!

2024/01/08 - Company

Discover the video of Sébastien Huron's wishes to all Virbac teams worldwide.

Read more

Outlook 2023-2024

2023/12/19 - Financial public releases

Read more